B Cells and Microbiota in Autoimmunity

Abstract

Trillions of microorganisms inhabit the mucosal membranes maintaining a symbiotic relationship with the host’s immune system. B cells are key players in this relationship because activated and differentiated B cells produce secretory immunoglobulin A (sIgA), which binds commensals to preserve a healthy microbial ecosystem. Mounting evidence shows that changes in the function and composition of the gut microbiota are associated with several autoimmune diseases suggesting that an imbalanced or dysbiotic microbiota contributes to autoimmune inflammation. Bacteria within the gut mucosa may modulate autoimmune inflammation through different mechanisms from commensals ability to induce B-cell clones that cross-react with host antigens or through regulation of B-cell subsets’ capacity to produce cytokines. Commensal signals in the gut instigate the differentiation of IL-10 producing B cells and IL-10 producing IgA+ plasma cells that recirculate and exert regulatory functions. While the origin of the dysbiosis in autoimmunity is unclear, compelling evidence shows that specific species have a remarkable influence in shaping the inflammatory immune response. Further insight is necessary to dissect the complex interaction between microorganisms, genes, and the immune system. In this review, we will discuss the bidirectional interaction between commensals and B-cell responses in the context of autoimmune inflammation.

TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer

“…IgA-secreting B cells are key players in maintaining a symbiotic relationship between the host's immune system and the commensal microbiome [ 39 ]. Disruption of this symbiotic relationship and hence of the interaction between bacteria and B cells has been implicated in several diseases, including some cancers [ 40 , 41 ]. To study the effect of bacteria on the anti-tumor B cells response, we depleted the microbiome by treating WT mice with a cocktail of four different antibiotics (ABX), as described in the Methods section.…”

Immune Phenomena in Myeloid Neoplasms: An “Egg or Chicken” Question

“…More recently, in ITP and chronic idiopathic neutropenia, a peculiar microbiota composition has been identified, possibly predictive of response to therapy (72). Similarly, alterations of the microbiota have been reported in SLE, RA, Multiple Sclerosis and Type-1 diabetes (73). Moreover, Parvovirus B19, hepatitis viruses, CMV and EBV have been associated with transitory forms of AA, probably due to a molecular mimicry between foreign and self-antigens or polyclonal immune stimulation.…”

Cancer Immunotherapy and Cytotoxicity: Current Advances and Challenges

“…Additionally, memory B cells (MBCs) have also been identified in humans and play an important role for the rapid development and response of protective immunity [95]. Collectively, with the aid of novel genetic and pharmacological technologies as well as the in-depth understanding of the phenotype, function and developmental processes, B cell-based cytotherapy has become a rapidly growing field in tumor immunotherapy [86,[94][95][96].…”